2020 Asian Pacific Society of Cardiology Consensus Recommendations on Antithrombotic Management for High-risk Chronic Coronary Syndrome
The unique characteristics of patients with chronic coronary syndrome (CCS) in the Asia-Pacific region, heterogeneous approaches because of differences in accesses and resources and low number of patients from the Asia-Pacific region in pivotal studies, mean that international guidelines cannot be r...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Radcliffe Medical Media
2021-06-01
|
Series: | European Cardiology Review |
Online Access: | https://www.ecrjournal.com/articleindex/ecr.2020.45 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1846122471574470656 |
---|---|
author | Jack Wei Chieh Tan Derek P Chew David Brieger John Eikelboom Gilles Montalescot Junya Ako Byeong-Keuk Kim David KL Quek Sarah J Aitken Clara K Chow Sok Chour Hung Fat Tse Upendra Kaul Isman Firdaus Takashi Kubo Boon Wah Liew Tze Tec Chong Kenny YK Sin Hung-I Yeh Wacin Buddhari Narathip Chunhamaneewat Faisal Hasan Keith AA Fox Quang Ngoc Nguyen Sidney TH Lo |
author_facet | Jack Wei Chieh Tan Derek P Chew David Brieger John Eikelboom Gilles Montalescot Junya Ako Byeong-Keuk Kim David KL Quek Sarah J Aitken Clara K Chow Sok Chour Hung Fat Tse Upendra Kaul Isman Firdaus Takashi Kubo Boon Wah Liew Tze Tec Chong Kenny YK Sin Hung-I Yeh Wacin Buddhari Narathip Chunhamaneewat Faisal Hasan Keith AA Fox Quang Ngoc Nguyen Sidney TH Lo |
author_sort | Jack Wei Chieh Tan |
collection | DOAJ |
description | The unique characteristics of patients with chronic coronary syndrome (CCS) in the Asia-Pacific region, heterogeneous approaches because of differences in accesses and resources and low number of patients from the Asia-Pacific region in pivotal studies, mean that international guidelines cannot be routinely applied to these populations. The Asian Pacific Society of Cardiology developed these consensus recommendations to summarise current evidence on the management of CCS and provide recommendations to assist clinicians treat patients from the region. The consensus recommendations were developed by an expert consensus panel who reviewed and appraised the available literature, with focus on data from patients in Asia-Pacific. Consensus statements were developed then put to an online vote. The resulting recommendations provide guidance on the assessment and management of bleeding and ischaemic risks in Asian CCS patients. Furthermore, the selection of long-term antithrombotic therapy is discussed, including the role of single antiplatelet therapy, dual antiplatelet therapy and dual pathway inhibition therapy. |
format | Article |
id | doaj-art-6e65974c60be45ae9133bd9a4386d9a8 |
institution | Kabale University |
issn | 1758-3756 1758-3764 |
language | English |
publishDate | 2021-06-01 |
publisher | Radcliffe Medical Media |
record_format | Article |
series | European Cardiology Review |
spelling | doaj-art-6e65974c60be45ae9133bd9a4386d9a82024-12-14T16:02:49ZengRadcliffe Medical MediaEuropean Cardiology Review1758-37561758-37642021-06-011610.15420/ecr.2020.452020 Asian Pacific Society of Cardiology Consensus Recommendations on Antithrombotic Management for High-risk Chronic Coronary SyndromeJack Wei Chieh Tan0Derek P Chew1David Brieger2John Eikelboom3Gilles Montalescot4Junya Ako5Byeong-Keuk Kim6David KL Quek7Sarah J Aitken8Clara K Chow9Sok Chour10Hung Fat Tse11Upendra Kaul12Isman Firdaus13Takashi Kubo14Boon Wah Liew15Tze Tec Chong16Kenny YK Sin17Hung-I Yeh18Wacin Buddhari19Narathip Chunhamaneewat20Faisal Hasan21Keith AA Fox22Quang Ngoc Nguyen23Sidney TH Lo24National Heart Centre, Singapore; Sengkang General Hospital, SingaporeCollege of Medicine and Public Health, Flinders University, Adelaide, AustraliaConcord Repatriation General Hospital, University of Sydney, Sydney, AustraliaMcMaster University, Ontario, CanadaSorbonne University, Paris, France; ACTION Study Group, France; Pitié-Salpêtrière University Hospital (AP-HP), Paris, FranceKitasato University and Hospital, Kanagawa, JapanYonsei University College of Medicine, South KoreaPantai Hospital Kuala Lumpur, Kuala Lumpur, MalaysiaUniversity of Sydney, Sydney, AustraliaWestmead Applied Research Centre, University of Sydney, Sydney, Australia; Westmead Hospital, Sydney, AustraliaCalmette Hospital, Phnom Penh, CambodiaQueen Mary Hospital, University of Hong Kong, Hong Kong, ChinaBatra Hospital and Medical Research Center, New Delhi, IndiaFaculty of Medicine, University of Indonesia, Jakarta, IndonesiaWakayama Medical University, Wakayama, JapanChangi General Hospital, SingaporeSingapore General Hospital, SingaporeNational Heart Centre, SingaporeMacKay Memorial Hospital, MacKay Medical College, Taipei, TaiwanKing Chulalongkorn Memorial Hospital, Bangkok, ThailandSiriraj Hospital, Mahidol University, Bangkok, ThailandHeart & Vascular Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab EmiratesUniversity of Edinburgh, Edinburgh, UKHanoi Medical University, Vietnam National Heart Institute, Hanoi, VietnamLiverpool Hospital, Sydney, AustraliaThe unique characteristics of patients with chronic coronary syndrome (CCS) in the Asia-Pacific region, heterogeneous approaches because of differences in accesses and resources and low number of patients from the Asia-Pacific region in pivotal studies, mean that international guidelines cannot be routinely applied to these populations. The Asian Pacific Society of Cardiology developed these consensus recommendations to summarise current evidence on the management of CCS and provide recommendations to assist clinicians treat patients from the region. The consensus recommendations were developed by an expert consensus panel who reviewed and appraised the available literature, with focus on data from patients in Asia-Pacific. Consensus statements were developed then put to an online vote. The resulting recommendations provide guidance on the assessment and management of bleeding and ischaemic risks in Asian CCS patients. Furthermore, the selection of long-term antithrombotic therapy is discussed, including the role of single antiplatelet therapy, dual antiplatelet therapy and dual pathway inhibition therapy.https://www.ecrjournal.com/articleindex/ecr.2020.45 |
spellingShingle | Jack Wei Chieh Tan Derek P Chew David Brieger John Eikelboom Gilles Montalescot Junya Ako Byeong-Keuk Kim David KL Quek Sarah J Aitken Clara K Chow Sok Chour Hung Fat Tse Upendra Kaul Isman Firdaus Takashi Kubo Boon Wah Liew Tze Tec Chong Kenny YK Sin Hung-I Yeh Wacin Buddhari Narathip Chunhamaneewat Faisal Hasan Keith AA Fox Quang Ngoc Nguyen Sidney TH Lo 2020 Asian Pacific Society of Cardiology Consensus Recommendations on Antithrombotic Management for High-risk Chronic Coronary Syndrome European Cardiology Review |
title | 2020 Asian Pacific Society of Cardiology Consensus Recommendations on Antithrombotic Management for High-risk Chronic Coronary Syndrome |
title_full | 2020 Asian Pacific Society of Cardiology Consensus Recommendations on Antithrombotic Management for High-risk Chronic Coronary Syndrome |
title_fullStr | 2020 Asian Pacific Society of Cardiology Consensus Recommendations on Antithrombotic Management for High-risk Chronic Coronary Syndrome |
title_full_unstemmed | 2020 Asian Pacific Society of Cardiology Consensus Recommendations on Antithrombotic Management for High-risk Chronic Coronary Syndrome |
title_short | 2020 Asian Pacific Society of Cardiology Consensus Recommendations on Antithrombotic Management for High-risk Chronic Coronary Syndrome |
title_sort | 2020 asian pacific society of cardiology consensus recommendations on antithrombotic management for high risk chronic coronary syndrome |
url | https://www.ecrjournal.com/articleindex/ecr.2020.45 |
work_keys_str_mv | AT jackweichiehtan 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome AT derekpchew 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome AT davidbrieger 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome AT johneikelboom 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome AT gillesmontalescot 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome AT junyaako 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome AT byeongkeukkim 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome AT davidklquek 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome AT sarahjaitken 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome AT clarakchow 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome AT sokchour 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome AT hungfattse 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome AT upendrakaul 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome AT ismanfirdaus 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome AT takashikubo 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome AT boonwahliew 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome AT tzetecchong 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome AT kennyyksin 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome AT hungiyeh 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome AT wacinbuddhari 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome AT narathipchunhamaneewat 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome AT faisalhasan 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome AT keithaafox 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome AT quangngocnguyen 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome AT sidneythlo 2020asianpacificsocietyofcardiologyconsensusrecommendationsonantithromboticmanagementforhighriskchroniccoronarysyndrome |